This prospective case-control study aims to evaluate the utility and establish laboratory thresholds for a multi-serotype urine antigen test for the diagnosis of pneumococcal community acquired pneumonia in children 5 years of age or younger in Guatemala.
Study Type
OBSERVATIONAL
Enrollment
959
Screening for Ag level in S. pneumoniae urinary antigen detection assay.
Hospital Regional Cuilapa
Cuilapa, Santa Rosa Department, Guatemala
Hospital General IGSS
Guatemala City, Guatemala
Hospital Roosevelt
Guatemala City, Guatemala
Urinary antigen detection cut-points for invasive S. pneumoniae disease
To determine Cut-Points to discriminate a positive or negative urine antigen test that differentiates invasive disease versus the carriage state
Time frame: Within 48 hours
Detection of S. pneumoniae serotypes using Urinary antigen detection assay
To determine the sensitivity and specificity of the Luminex xMPA pneumococcal UAD in the identification of S. pneumoniae serotypes (PCV13 serotypes) in children with radiologically confirmed CAP
Time frame: Within 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.